Hasty Briefsbeta

Bilingual

Type 1 Diabetes: A Review - PubMed

7 days ago
  • #Autoimmune Disease
  • #Type 1 Diabetes
  • #Insulin Therapy
  • Type 1 diabetes is caused by autoimmune destruction of insulin-producing beta cells, leading to insulin deficiency.
  • It accounts for 5% to 10% of all diabetes cases, affecting about 2 million people in the US and 8.4 million worldwide.
  • Complications include retinopathy, nephropathy, neuropathy, and cardiovascular disease.
  • 90% to 95% of patients have at least one autoantibody at diagnosis, which can identify early stages of the disease.
  • Up to 44% of children and 23% of adults present with diabetes-related ketoacidosis.
  • The median age of diagnosis in the US is 24 years, though it is most commonly diagnosed between ages 10 and 14.
  • Lifelong insulin replacement is required, administered via injection or pump.
  • Continuous glucose monitors with insulin pumps improve hemoglobin A1c levels and reduce hypoglycemia.